Neisseria gonorrhoeae, TMA (Alternate Target), Urogenital

Swabs: Swab must be submitted in Aptima® Multitest Collection Kit (orange label), or Unisex Swab Specimen Collection Kit (white label). Follow instructions in the Aptima® Swab Specimen Collection Kits for Vaginal, Endocervical and Urethral Swab Specimens package insert. In females, to ensure collection of an adequate specimen, columnar epithelial cells lining the endocervix should be obtained. To that effect, excess mucus should be removed prior to sampling by using the white shaft cleaning swab which is discarded after use.
Collection Container: Aptima® Multitest Collection Kit (orange label), or Unisex Swab Specimen Collection Kit (white label).

Urine: Urine must be submitted in Aptima® Urine Specimen Collection tube within 24 hours of collection. The patient should not have urinated for at least one hour prior to specimen collection. Direct patient to provide a first-catch urine (approximately 20-30 mL of the initial urine stream) into a urine collection cup free of any preservatives. Collection of larger volumes of urine may result in specimen dilution that may reduce test sensitivity. Female patients should not cleanse the labial area prior to providing the specimen. Thus, a urine sample collected from a female for Chlamydia/GC TMA cannot be collected at the same voiding event as that urine which would be intended for bacterial culture. Remove the cap of the Aptima® Urine Specimen Collection Tube and transfer 2 mL of urine into the urine specimen transport tube using the disposable pipette provided. The correct volume of urine has been added when the fluid level is between the black lines within the clear pane on the urine specimen transport tube label.
Collection Container: Aptima® Urine Specimen Collection Tube (white label).

ThinPrep® PreservCyt®: Transfer 1 mL of ThinPrep® PreservCyt® solution into Aptima® Specimen Transfer tube (green label) or Aptima® Multitest Collection Tube (orange label).

Note: Results from the Aptima® Combo 2 Assay should be interpreted in conjunction with other laboratory and clinical data available to the clinician.

The Aptima® Combo 2 Assay is not intended for the evaluation of suspected sexual abuse or for other medico-legal indications.

For a complete list of assay limitations we recommend that you review the manufacturers package insert, https://www.hologic.com/package-inserts/diagnostic-products/aptima-combo-2-assay-ctng.